Iron Tartrate

Iron tartrate is an iron salt compound formed by combining iron with tartaric acid, theoretically designed to provide supplemental iron. However, no clinical trials have established its effectiveness or safety profile for iron deficiency treatment.

Origin & History

Iron tartrate is a coordination complex salt formed between iron ions (Fe²⁺ or Fe³⁺) and tartaric acid, a naturally occurring compound found in grapes, tamarinds, and bananas. It is produced through chemical synthesis by reacting iron salts with tartaric acid, yielding forms like ferrous tartrate (C₄H₆FeO₆) or ferric tartrate (C₁₂H₁₂Fe₂O₁₈), with iron content around 20% in ferric forms.

Historical & Cultural Context

No historical or traditional medicine uses for iron tartrate are documented in the available sources. The research focuses exclusively on chemical properties without mention of use in traditional systems like Ayurveda or Traditional Chinese Medicine.

Health Benefits

• No clinically proven health benefits - no human trials identified in available research
• Potential iron supplementation - theoretical benefit as an iron salt, but no specific evidence
• No documented therapeutic effects - research limited to chemical structure data
• No established medical uses - DrugBank lists the compound but notes no detailed applications
• Insufficient evidence - all potential benefits remain unsubstantiated by clinical research

How It Works

Iron tartrate theoretically releases elemental iron in the digestive tract through dissociation of the iron-tartrate bond. The released iron would then follow standard iron absorption pathways via divalent metal transporter 1 (DMT1) and ferroportin in intestinal enterocytes. The tartaric acid component may theoretically enhance iron solubility, though this mechanism remains unproven in clinical settings.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses specifically on iron tartrate were identified in the available sources. The research consists solely of chemical structure and property data from PubChem and DrugBank databases, with no linked PubMed citations or clinical studies.

Clinical Summary

No human clinical trials have been conducted specifically on iron tartrate supplementation. Available research is limited to chemical characterization and structural analysis studies. Unlike other iron salts such as ferrous sulfate or ferrous gluconate, iron tartrate lacks documented efficacy data for treating iron deficiency anemia. The absence of clinical evidence makes it impossible to establish therapeutic dosages or compare its bioavailability to proven iron supplements.

Nutritional Profile

Iron tartrate is an iron salt of tartaric acid, providing elemental iron (Fe²⁺/Fe³⁺) as its primary micronutrient contribution. Elemental iron content varies by salt ratio, but iron tartrate typically yields approximately 20-25% elemental iron by molecular weight (based on ferrous tartrate: Fe molecular weight 55.85 g/mol within total MW ~203.94 g/mol). As an iron salt, it theoretically contributes bioavailable iron for hemoglobin synthesis and enzymatic function. The tartrate anion (derived from tartaric acid, C₄H₆O₆) is a naturally occurring organic acid found in grapes and wine. Bioavailability data specific to iron tartrate is absent from clinical literature; however, organic iron salts generally demonstrate moderate bioavailability compared to ferrous sulfate (the reference standard at ~20% absorption). The tartrate component may modestly improve solubility in gastric conditions relative to inorganic iron salts. No established serving size, RDA contribution percentage, or macronutrient content is documented — this compound is characterized primarily through its chemical structure rather than nutritional profiling studies.

Preparation & Dosage

No clinically studied dosage ranges have been established for iron tartrate, as no human trials are available. Commercial products specify iron content (~20% Fe in ferric forms) but lack dosing guidance. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C (ascorbic acid) is the most well-established iron absorption enhancer, reducing Fe³⁺ to the more absorbable Fe²⁺ form and chelating iron to prevent inhibitory compound formation — pairing 25-100mg ascorbic acid with iron salts can increase non-heme iron absorption by 2-4 fold. L-lysine (500mg range) has been shown to enhance iron absorption through competitive inhibition of inhibitory polyphenol binding at intestinal absorption sites, making it a useful co-factor. Folic acid (vitamin B9) pairs synergistically because both iron and folate address overlapping pathways in red blood cell production and anemia prevention — iron supports hemoglobin synthesis while folate enables erythrocyte maturation, creating complementary hematopoietic support. Copper (as copper gluconate or bisglycinate, ~1-2mg) is essential for ceruloplasmin activity, which oxidizes Fe²⁺ to Fe³⁺ for transferrin binding and cellular iron transport, meaning copper deficiency directly impairs iron utilization regardless of iron intake.

Safety & Interactions

Safety profile remains undefined due to lack of clinical testing in humans. Theoretical side effects would mirror other iron supplements, including gastrointestinal upset, constipation, and potential iron overload with excessive intake. Iron supplements generally interact with antibiotics, thyroid medications, and calcium supplements by reducing absorption. Pregnant women should avoid iron tartrate specifically due to insufficient safety data, despite iron being essential during pregnancy.